Research Review: 1 Single Low Dose of Esketamine after Childbirth Shows Promise for PPD
A single low dose of esketamine administered right after childbirth shows promise for postpartum depression, showing it could be a viable treatment option for new mothers showing signs of prenatal depression.
Research Review: Ketamine VS Morphine for Acute Pain Relief in the ER
Ketamine shows better faster relief with fewer adverse events.
IV Ketamine Shows Potential Promise for Refractory Headache in Children
The retrospective study analyzed 68 treatment sessions involving 41 patients aged 5-21 years, predominantly girls with chronic migraine without aura. Patients were administered a median dose of 0.25 mg/kg/hr of IV ketamine over a median duration of 3 days.
